Search
Skip to Search Results- 4Amyotrophic Lateral Sclerosis (ALS)
- 2Peak Cough Flow (PCF)
- 1Airway clearance
- 1Aura Matrix
- 1Biomarkers
- 1Brain Parenchymal Fraction (BPF)
-
2012-04-02
Thoresen-Semonick, Christina, Wunderlich, Lorielle, Cust, Sarah
Peak cough flow (PCF) is a measure of cough strength and capacity. According to American Thoracic Society (ATS) standards, patients should be seated upright during pulmonary function testing. However, the effect of sitting angle on PCF and other measures of cough function in patients with ALS has...
-
2010-12-03
Wilson, Lindsay, Lawson, Ben, Stupka, Erika, Soderquist, Stephanie
Purpose The primary purpose of this 900 project was to explore the effects of Lung Volume Recruitment (LVR) on voice and speech in patients with Amyotrophic Lateral Sclerosis (ALS) through the development of analysis protocols for several dependent measures. Methods Speech and voice data from a...
-
2011-06-28
Ostertag, Amanda, Ketch, Rhonda, Moncks, Nadine, Erickson, Dorie
Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease characterized by the degeneration of both upper and lower motor neurons. These impairments cause functional limitations in many motor systems, including those supporting respiration and swallowing. As ALS progresses, specific...
-
2014
Maani, Rouzbeh, Kalra, Sanjay, Yang, Yee-Hong
In this paper, we applied texture analysis to evaluate cerebral degeneration in amyotrophic lateral sclerosis (ALS). Two well-known methods, the gray level co-occurrence matrix (GLCM) and the gray level aura matrix (GLAM) were employed to extract texture features from routine T1 and T2 MR images....